TEANECK, N.J., Feb. 15, 2012 /PRNewswire/ -- Herborium Group,
Inc., (Pink Sheets: HBRM) www.herborium.com, a Botanical
Therapeutics® company, announced today its plan to launch an
aggressive marketing campaign targeting sales of its proprietary,
all botanical acne treatment -- AcnEase® -- to the most
affluent ethnic market in the US that is Asian Indian and Asian
Indian Decent population. AcnEase is a perfect match for the
Indian market with its rising purchasing power and fashion
consciousness combined with preference for natural, herbal based
products. Most importantly, AcnEase while proven effective
to eliminate symptoms of acne will not discolor or bleach darker
complexion; the problem that may result from using many topical
products on the market.
"We have hired Mr. Karan Sharma,
also a Director of Elite Enterprises LTD of US and Mumbai, whose experience includes 15 years of
building vast Ethnic Indian distribution networks in the US and UK
to lead our efforts in providing our unique acne treatment to
Indian Ethnic markets. We are very excited about Mr. Sharma
joining the Herborium team," stated Dr. Agnes P. Olszewski, CEO of Herborium.
"According to the latest National Census, Asian Indians have the
highest Median Family Income in the US ($101,000/year) and the highest rate of
any ethnic groups (64.4%) of college degrees. We believe that these
demographics, together with our product's unique characteristics
and benefits, and Mr. Sharma's expertise provide for
powerful revenue and market share drivers in the
profitable Indian Ethnic market," added Dr. Olszewski.
"We also treat our entry into Indian Ethnic markets in the US
and UK as the first step in a future expansion to Indian market.
Indian cosmetic industry is estimated to grow around 22% during
2011-2014," concluded Dr. Olszewski.
About AcnEase®:
AcnEase® is unique all botanical
therapeutic® for acne. Over 130 million people are affected by
acne in the US and Europe alone.
Herborium's AcnEase® results are very impressive,
with up to 95% of both females and males seeing significant
improvement after the first course of treatment
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company sells
its products in the US and Europe.
For more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
